“It’s easy to say that we should consume fewer calories – but at the same time, we all like to eat,” says study leader Philipp E. Scherer, Ph.D., professor in the departments of internal medicine and cell biology at UTSW. “By absorbing fewer lipids, these animals kept their weight down and did not experience the secondary consequences of excess weight gain.”
It has long been known that systemic iron deficiencies cause anemia, explains Scherer, with symptoms including extreme fatigue and weakness. Researchers have also investigated the effects of depriving specific cell populations of iron, which typically causes cells to become dysfunctional and even die. However, he adds, researchers have not tested this manipulation in fat cells.
When Scherer and his team used a breeding technique to generate mice with significantly lower iron content in their fat cells, the scientists expected the resulting animals to be in poor health. On the contrary, they remained healthy, even when fed a high-fat diet that drove their cage mates to become severely obese. While the normal “wild type” mice developed health problems associated with obesity, including insulin resistance and high levels of cholesterol and triglycerides, the mice with iron-poor fat tissue were leaner and developed none of these issues. A different genetic manipulation that lowered iron content in fat cells of adult mice produced the same positive health effects, protecting the mice from metabolic disorders induced by a high-fat diet, and even improving the health of mice after they became obese, reversing most of the negative obesity-associated consequences.
Searching for what caused this phenomenon, Scherer and his colleagues discovered that the intestinal cells of mice with iron-poor fat absorbed fewer lipids, significantly limiting the number of calories they took in. Scherer suggests that iron-deficient fat cells may send a chemical signal to communicate their iron status to the intestine, triggering the tissue to take up fewer lipids. However, the nature of this signal is yet unknown.
If researchers could find a way to safely deplete fat cells of iron or artificially supply the chemical signal, they may eventually be able to improve metabolic health in people.
“Finding how fat is talking to the intestines is the next step we have to embark upon,” Scherer says.
Zhuzhen Zhang in the Scherer laboratory was first author of this study. Other researchers who contributed include Jan-Bernd Funcke, Zhenzhen Zi, Shangang Zhao, Leon Straub, Qingzhang Zhu, Clair Crewe, Yu (Aaron) An, Shiuhwei Chen, Na Li, May-Yun Wang, Alexandra L. Ghaben, Charlotte Lee, Laurent Gautron, Luke J. Engelking, Prithvi Raj, Yingfeng Deng, Ruth Gordillo, and Christine M. Kusminski, all of UT Southwestern, and Yi Zhu of Baylor College of Medicine.
This study was funded by National Institutes of Health grants RC2-DK118620, R01-DK55758, R01-DK099110, P01-DK088761, P01-AG051459, AHA825982, and K01-DK125447.
Scherer holds the Gifford O. Touchstone, Jr. and Randolph G. Touchstone Distinguished Chair in Diabetes Research, and the Touchstone/West Distinguished Chair in Diabetes Research.
About UT Southwestern Medical Center
UT Southwestern, one of the premier academic medical centers in the nation, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty has received six Nobel Prizes, and includes 24 members of the National Academy of Sciences, 16 members of the National Academy of Medicine, and 13 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 2,800 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in about 80 specialties to more than 117,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 3 million outpatient visits a year.